tiprankstipranks
Seelos Therapeutics (SEEL)
NASDAQ:SEEL

Seelos Therapeutics (SEEL) Financial Statements

1,126 Followers

Seelos Therapeutics Financial Overview

Seelos Therapeutics's market cap is currently ―. The company's EPS TTM is $-42.747; its P/E ratio is -0.01; Seelos Therapeutics is scheduled to report earnings on August 2, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 579.00K$ 406.00K$ 336.00K$ 875.00K$ 40.00K
Gross Profit$ 579.00K$ 406.00K$ 336.00K$ 875.00K$ 40.00K
EBIT$ -2.44M$ 10.54M$ -29.49M$ -9.19M$ -15.64M
EBITDA$ -2.42M$ 10.55M-$ -9.18M$ -15.59M
Net Income Common Stockholders$ -2.66M$ 10.50M$ -29.50M$ -13.43M$ -18.66M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 500.00K$ 2.58M$ 5.80M$ 14.10M$ 15.50M
Total Assets$ 3.61M$ 6.22M$ 11.89M$ 23.68M$ 22.75M
Total Debt$ 13.14M$ 16.91M$ 15.34M$ 16.78M$ 20.12M
Net Debt$ 12.64M$ 14.32M$ 9.54M$ 2.68M$ 4.62M
Total Liabilities$ 36.72M$ 36.63M$ 59.07M$ 44.30M$ 33.36M
Stockholders Equity$ -33.10M$ -30.41M$ -47.18M$ -20.68M$ -10.61M
Cash Flow-
Free Cash Flow$ -4.64M$ -5.75M-$ -10.35M$ -13.09M
Operating Cash Flow$ -4.64M$ -5.75M$ -5.90M$ -10.35M$ -13.09M
Investing Cash Flow-----
Financing Cash Flow$ 2.17M$ 2.49M$ -2.31M$ 8.87M$ -1.89M
Currency in USD

Seelos Therapeutics Earnings and Revenue History

Seelos Therapeutics Debt to Assets

Seelos Therapeutics Cash Flow

Seelos Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis